CN104507483A - 益生元组合物及使用方法 - Google Patents

益生元组合物及使用方法 Download PDF

Info

Publication number
CN104507483A
CN104507483A CN201380031058.6A CN201380031058A CN104507483A CN 104507483 A CN104507483 A CN 104507483A CN 201380031058 A CN201380031058 A CN 201380031058A CN 104507483 A CN104507483 A CN 104507483A
Authority
CN
China
Prior art keywords
prebiotic composition
composition
subject
prebiotic
bifidobacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380031058.6A
Other languages
English (en)
Chinese (zh)
Inventor
D·S·纽伯格
Z·于
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston College
Original Assignee
Boston College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston College filed Critical Boston College
Publication of CN104507483A publication Critical patent/CN104507483A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/533—Longum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201380031058.6A 2012-04-13 2013-03-13 益生元组合物及使用方法 Pending CN104507483A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261623868P 2012-04-13 2012-04-13
US61/623,868 2012-04-13
PCT/US2013/030764 WO2013154725A1 (en) 2012-04-13 2013-03-13 Prebiotic compositions and methods of use

Publications (1)

Publication Number Publication Date
CN104507483A true CN104507483A (zh) 2015-04-08

Family

ID=49328018

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380031058.6A Pending CN104507483A (zh) 2012-04-13 2013-03-13 益生元组合物及使用方法

Country Status (6)

Country Link
US (1) US20150265661A1 (https=)
EP (1) EP2836218A4 (https=)
JP (1) JP2015512936A (https=)
CN (1) CN104507483A (https=)
MX (1) MX2014012362A (https=)
WO (1) WO2013154725A1 (https=)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108348536A (zh) * 2015-11-17 2018-07-31 格礼卡姆股份公司 治疗抗生素相关性并发症的合成组合物
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN110257299A (zh) * 2019-07-11 2019-09-20 锦州医科大学 一种阴沟肠杆菌在促进反刍动物生长的应用
CN111363671A (zh) * 2020-02-26 2020-07-03 天津医科大学 一种肠道厌氧微生物培养瓶及其制备方法
CN112075637A (zh) * 2020-04-27 2020-12-15 合生元（广州）健康产品有限公司 一种减少肠道气体产生的组合物
CN112841543A (zh) * 2021-01-28 2021-05-28 重庆周师兄餐饮文化有限公司 一种麻辣脆的加工方法
CN112869168A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 可提高胃肠道免疫能力的益生菌益生元组合物及其应用
CN112890200A (zh) * 2021-03-08 2021-06-04 合生元（广州）健康产品有限公司 用于促进低体重婴幼儿生长追赶的一种营养组合物
WO2021197492A1 (zh) * 2020-04-03 2021-10-07 内蒙古伊利实业集团股份有限公司 可提升生物体对金黄色葡萄球菌感染的抵御能力的母乳低聚糖
CN113796545A (zh) * 2021-09-13 2021-12-17 合生元（广州）健康产品有限公司 调节肠道免疫功能的母乳低聚糖组合物及其应用
CN114981407A (zh) * 2020-01-20 2022-08-30 森永乳业株式会社 细菌、组合物及其制造方法、以及益生元组合物
CN115920013A (zh) * 2022-11-15 2023-04-07 合生元（广州）健康产品有限公司 乳源成分在降低单增李斯特菌引起的感染风险中的应用
CN116042486A (zh) * 2023-02-22 2023-05-02 高邮市人民医院 一种用于治疗动脉粥样硬化的复合菌制剂

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2651067T3 (es) 2009-07-06 2018-01-24 Children's Hospital Medical Center Inhibición de la inflamación con oligosacáridos de la leche
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
WO2014036182A2 (en) 2012-08-29 2014-03-06 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP2885977A1 (en) * 2013-12-19 2015-06-24 Agriculture and Food Development Authority (TEAGASC) An oligosaccharide-enriched composition having immune-modulatory and anti-adhesion properties
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
PL3209673T5 (pl) 2014-10-24 2023-10-23 Glycom A/S Mieszaniny hmo
US11040049B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
EP3212197A4 (en) 2014-10-29 2018-07-11 Glycom A/S Synthetic composition and method for treating irritable bowel syndrome
EP3212198B1 (en) * 2014-10-29 2020-12-23 Glycom A/S Synthetic composition and method for promoting mucosal healing
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
CA2966360C (en) 2014-10-30 2023-09-05 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
WO2016069801A1 (en) 2014-10-30 2016-05-06 California Institute Of Technology Compositions and methods comprising bacteria for improving behavior in neurodecelopmental disorders
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
EP3229812A4 (en) 2014-12-08 2018-10-03 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
AR103260A1 (es) * 2014-12-23 2017-04-26 4D Pharma Res Ltd Modulación inmunitaria
EP3400953A1 (en) 2014-12-23 2018-11-14 4D Pharma Research Limited Pirin polypeptide and immune modulation
AU2018205072B2 (en) * 2014-12-23 2020-05-21 Cj Bioscience, Inc. Immune modulation
EP3288389A4 (en) 2015-04-28 2018-10-10 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
WO2016203221A1 (en) 2015-06-15 2016-12-22 4D Pharma Research Limited Compositions comprising bacterial strains
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
SMT201900588T1 (it) 2015-06-15 2019-11-13 4D Pharma Res Limited Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
NZ737752A (en) 2015-06-15 2022-02-25 4D Pharma Res Ltd Compositions comprising bacterial strains
US10780103B2 (en) 2015-10-28 2020-09-22 Glycom A/S Synthetic composition and method for modulating emotion and mood disorders
PL3368046T3 (pl) * 2015-10-28 2022-11-28 Glycom A/S Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
EP3389668A4 (en) 2015-12-15 2019-08-21 Glycom A/S MIXTURE OF HMOS
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
ME03487B (me) 2016-03-04 2020-01-20 4D Pharma Plc Kompozicije koje sadrže blautia bakterijske sojeve za liječenje visceralne hipersenzitivnosti
EP3429604A1 (en) 2016-03-14 2019-01-23 Holobiome, Inc. Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
DK3452050T3 (da) * 2016-05-05 2023-02-20 Glycom As Composition comprising hmos for the treatment of noninfectious diarrhoea
US11224605B2 (en) 2016-05-19 2022-01-18 Glycom A/S Synthetic composition
EP4548925A3 (en) 2016-07-01 2025-07-09 Infinant Health, Inc Method for facilitating maturation of the mammalian immune system
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
SG10202100843TA (en) 2016-07-28 2021-03-30 Fonterra Cooperative Group Ltd Dairy product and process
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
US11566238B2 (en) 2016-12-15 2023-01-31 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
WO2018155995A1 (ko) * 2017-02-27 2018-08-30 한국생명공학연구원 시아릴락토오스를 유효성분으로 포함하는 항균용 조성물
JP2020513014A (ja) * 2017-04-07 2020-04-30 チルドレンズ ホスピタル メディカル センター ２’−フコシルラクトース化合物による炎症性腸疾患の治療
DK3630136T3 (da) 2017-05-22 2021-05-25 4D Pharma Res Ltd Sammensætninger, der omfatter bakteriestammer
EP3630942B1 (en) 2017-05-24 2022-11-30 4D Pharma Research Limited Compositions comprising bacterial strain
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
SMT202000555T1 (it) 2017-06-14 2020-11-10 4D Pharma Res Limited Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi
CA3066189A1 (en) 2017-06-14 2018-12-20 4D Pharma Research Limited Compositions comprising bacterial strains
CN111356461A (zh) * 2017-10-04 2020-06-30 加利福尼亚大学董事会 免疫调节性低聚糖
KR102741265B1 (ko) * 2017-11-30 2024-12-11 글리콤 에이/에스 미생물총 조절을 위한 인간 밀크 올리고당 및 그의 합성 조성물
WO2019123316A1 (en) * 2017-12-22 2019-06-27 Glycom A/S Composition comprising hmos for preventing or reducing nociception
AU2019232004A1 (en) * 2018-03-08 2020-10-01 Plexus Worldwide Llc Compositions and methods for skin renewal
WO2020174386A1 (en) 2019-02-25 2020-09-03 Nutribam Bvba Composition, food supplement and method for supporting and/or improving intestinal health
BE1027078A9 (nl) * 2019-02-25 2020-09-28 Nutribam Bvba Samenstelling, voedingssupplement en werkwijze voor het ondersteunen en/of verbeteren van de darmgezondheid
MX2023008202A (es) 2021-01-29 2023-07-18 Nestle Sa Mezcla de hmo y bifidobacteria.
WO2022223430A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. A composition of enzymes and human milk oligosaccharides
AU2022307441A1 (en) * 2021-07-09 2024-01-25 Société des Produits Nestlé S.A. Uses of bifidobacterium longum transitional microorganism
KR102411242B1 (ko) * 2021-10-18 2022-06-22 큐티스바이오 주식회사 클렙시엘라 아에로제네스의 피부 상태 개선 용도
DK202200588A1 (en) 2022-06-20 2024-02-23 Dsm Ip Assets Bv Mixture of fucosylated HMOs

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011005681A1 (en) * 2009-07-06 2011-01-13 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
US20110158950A1 (en) * 2009-12-28 2011-06-30 Suomen Punainen Risti Veripalvelu Use of blood group status i
WO2011136647A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant and toddler nutrition
CN103338775A (zh) * 2010-12-31 2013-10-02 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
CN103347405A (zh) * 2011-02-10 2013-10-09 雀巢产品技术援助有限公司 使用人乳中发现的寡糖的组合调节双歧杆菌属的生长
CN103442717A (zh) * 2010-11-23 2013-12-11 雀巢产品技术援助有限公司 用于治疗皮肤疾病的包含水解的蛋白质和寡糖的组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630452B2 (en) * 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
US20060127546A1 (en) * 2004-08-27 2006-06-15 Purac Biochem B.V. Use of glycine and/or glycine derivatives as antibacterial agent against gram negative bacterial pathogens in foods and/or drinks

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011005681A1 (en) * 2009-07-06 2011-01-13 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
US20110158950A1 (en) * 2009-12-28 2011-06-30 Suomen Punainen Risti Veripalvelu Use of blood group status i
WO2011136647A1 (en) * 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant and toddler nutrition
CN103442717A (zh) * 2010-11-23 2013-12-11 雀巢产品技术援助有限公司 用于治疗皮肤疾病的包含水解的蛋白质和寡糖的组合物
CN103338775A (zh) * 2010-12-31 2013-10-02 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
CN103347405A (zh) * 2011-02-10 2013-10-09 雀巢产品技术援助有限公司 使用人乳中发现的寡糖的组合调节双歧杆菌属的生长

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108348536A (zh) * 2015-11-17 2018-07-31 格礼卡姆股份公司 治疗抗生素相关性并发症的合成组合物
CN108935698A (zh) * 2018-09-11 2018-12-07 内蒙古伊利实业集团股份有限公司 一种预防小儿腹泻疾病的营养组合物及应用
CN110257299A (zh) * 2019-07-11 2019-09-20 锦州医科大学 一种阴沟肠杆菌在促进反刍动物生长的应用
CN110257299B (zh) * 2019-07-11 2022-06-10 锦州医科大学 一种阴沟肠杆菌在促进反刍动物生长的应用
CN112869168B (zh) * 2019-11-29 2023-06-06 内蒙古伊利实业集团股份有限公司 可提高胃肠道免疫能力的益生菌益生元组合物及其应用
CN112869168A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 可提高胃肠道免疫能力的益生菌益生元组合物及其应用
CN114981407A (zh) * 2020-01-20 2022-08-30 森永乳业株式会社 细菌、组合物及其制造方法、以及益生元组合物
CN111363671A (zh) * 2020-02-26 2020-07-03 天津医科大学 一种肠道厌氧微生物培养瓶及其制备方法
CN111363671B (zh) * 2020-02-26 2023-07-21 天津医科大学 一种肠道厌氧微生物培养瓶及其制备方法
WO2021197492A1 (zh) * 2020-04-03 2021-10-07 内蒙古伊利实业集团股份有限公司 可提升生物体对金黄色葡萄球菌感染的抵御能力的母乳低聚糖
EP4129302A4 (en) * 2020-04-03 2024-04-17 Inner Mongolia Yili Industrial Group Co., Ltd. BREAST MILK CHOLIGOSACCHARIDES TO IMPROVE AN ORGANISM'S RESISTANCE TO STAPHYLOCOCCUS AUREUS INFECTIONS
WO2021217803A1 (zh) * 2020-04-27 2021-11-04 合生元（广州）健康产品有限公司 一种减少肠道气体产生的组合物
CN112075637A (zh) * 2020-04-27 2020-12-15 合生元（广州）健康产品有限公司 一种减少肠道气体产生的组合物
CN112075637B (zh) * 2020-04-27 2023-05-23 合生元（广州）健康产品有限公司 一种减少肠道气体产生的组合物
CN112841543A (zh) * 2021-01-28 2021-05-28 重庆周师兄餐饮文化有限公司 一种麻辣脆的加工方法
CN112890200B (zh) * 2021-03-08 2021-11-12 合生元（广州）健康产品有限公司 用于促进低体重婴幼儿生长追赶的一种营养组合物
CN112890200A (zh) * 2021-03-08 2021-06-04 合生元（广州）健康产品有限公司 用于促进低体重婴幼儿生长追赶的一种营养组合物
CN113796545A (zh) * 2021-09-13 2021-12-17 合生元（广州）健康产品有限公司 调节肠道免疫功能的母乳低聚糖组合物及其应用
CN115920013A (zh) * 2022-11-15 2023-04-07 合生元（广州）健康产品有限公司 乳源成分在降低单增李斯特菌引起的感染风险中的应用
CN116042486A (zh) * 2023-02-22 2023-05-02 高邮市人民医院 一种用于治疗动脉粥样硬化的复合菌制剂

Also Published As

Publication number Publication date
EP2836218A1 (en) 2015-02-18
JP2015512936A (ja) 2015-04-30
US20150265661A1 (en) 2015-09-24
EP2836218A4 (en) 2015-10-21
WO2013154725A1 (en) 2013-10-17
MX2014012362A (es) 2015-05-07

Similar Documents

Publication Publication Date Title
CN104507483A (zh) 益生元组合物及使用方法
US9603876B2 (en) Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
EP3468573B1 (en) Treatment of clostridium difficile infection
US9649348B2 (en) Compositions and method for treatment and prophylaxis of inflammatory bowel disease
CN103987393B (zh) 包括与益生菌联合的n-乙酰半胱氨酸和/或微胶囊化的胃保护性溶菌酶的组合物
CN103491969A (zh) 恢复和重建肠道微生物群的合生素组合物
US20240293483A1 (en) Probiotic composition for the treatment of increased intestinal permeability
EP2415475B1 (en) Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum
CN116439377A (zh) 一种用于缓解婴幼儿菌群失调的营养组合物及其用途
CN114728028A (zh) 包括具有增强的持久性的新微生物的组合物、新微生物和益生元的协同组合
KR20240093392A (ko) 질병 치료를 위한 조성물 및 방법
JP6837992B2 (ja) 非伝達性の抗生物質耐性を有し、同じ治療適応症を有する乳酸菌および／またはビフィズス菌の同時使用と組合せた、特定の治療活性を有する抗生物質の使用
WO2022161928A1 (en) Probiotic composition comprising lactobacillus salivarius and bifidobacterium longum and its uses
WO2011080395A2 (en) Use of blood group status i
EP4701442A1 (en) Lacto-n-fucopentaose and b. infantis to protect from enteric pathogens
WO2021067167A1 (en) Clostrodioides difficile treatment
TWI897570B (zh) 長雙歧桿菌及其用於降低血液中氧化三甲胺及增加腸道中艾克曼嗜黏蛋白菌含量的用途
Favaron et al. The ageing microbiome, pharmaceutical considerations, and therapeutic opportunities
US20250205292A1 (en) Pharmaceutical compositions and uses thereof
US20120315250A1 (en) Probiotic bifidobacterial composition in accordance with secretor blood group status
CN121852271A (zh) 益生大肠杆菌CP57 (Escherichia coli CP57)及其应用
HK40007703B (en) Treatment of clostridium difficile infection
HK40007703A (en) Treatment of clostridium difficile infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150408

WD01 Invention patent application deemed withdrawn after publication